Literature DB >> 19579025

CYP1A2 genotype and rheumatoid arthritis in Koreans.

Marilyn C Cornelis1, Sang-Cheol Bae, Il Kim, Ahmed El-Sohemy.   

Abstract

Cytochrome P540 (CYP) 1A2 plays a role in the production of reactive oxygen species (ROS), which have been implicated in the development of rheumatoid arthritis (RA). The objective of this study was to investigate the association between a common polymorphism in the CYP1A2 gene with risk and severity of RA in a Korean population. Cases (n = 1321) with RA and controls (n = 1037) were genotyped for the CYP1A2 -163 A>C polymorphism by real-time PCR. HLA-DRB1 typing and further subtyping of all alleles was performed by PCR, sequence-specific oligonucleotide probe hybridization and direct DNA sequencing analysis. The odds ratio (OR) [(95% confidence interval (CI)] of RA associated with the low inducible C allele was 1.11 (0.80-1.55) among non-shared epitope (SE) carriers, 0.82 (0.56-1.20) among heterozygotes and 0.32 (0.10-1.04) among individuals homozygous for the SE (P = 0.03 for CYP1A2-SE interaction). A protective effect of the low inducibility CYP1A2 C allele among carriers of the SE suggests that a product of CYP1A2-mediated metabolism, such as ROS, may be involved in the development of RA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19579025     DOI: 10.1007/s00296-009-1050-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  46 in total

1.  Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.

Authors:  Roza Ghotbi; Magnus Christensen; Hyung-Keun Roh; Magnus Ingelman-Sundberg; Eleni Aklillu; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2007-03-17       Impact factor: 2.953

2.  Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.

Authors:  L Gu; F J Gonzalez; W Kalow; B K Tang
Journal:  Pharmacogenetics       Date:  1992-04

3.  Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium.

Authors:  G S Firestein; F Echeverri; M Yeo; N J Zvaifler; D R Green
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

4.  Manganese superoxide dismutase and cytochrome P450 1A1 genes polymorphisms in rheumatoid arthritis in Taiwan.

Authors:  Jeng-Hsien Yen; Chung-Jen Chen; Wen-Chun Tsai; Chia-Hui Lin; Tsan-Teng Ou; Chaur-Jong Hu; Hong-Wen Liu
Journal:  Hum Immunol       Date:  2003-03       Impact factor: 2.850

5.  Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes.

Authors:  S Puntarulo; A I Cederbaum
Journal:  Free Radic Biol Med       Date:  1998-05       Impact factor: 7.376

6.  Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes.

Authors:  H Yamazaki; P M Shaw; F P Guengerich; T Shimada
Journal:  Chem Res Toxicol       Date:  1998-06       Impact factor: 3.739

7.  A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis.

Authors:  Leonid Padyukov; Camilla Silva; Patrik Stolt; Lars Alfredsson; Lars Klareskog
Journal:  Arthritis Rheum       Date:  2004-10

8.  Interaction between RANKL and HLA-DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort.

Authors:  Hui Wu; Dinesh Khanna; Grace Park; Vivian Gersuk; Gerald T Nepom; Weng Kee Wong; Harold E Paulus; Betty P Tsao
Journal:  Arthritis Rheum       Date:  2004-10

9.  Quantitation of rheumatoid factor activity by nephelometry.

Authors:  C E Jones; R J Rousseau; K W Maxwell
Journal:  Am J Clin Pathol       Date:  1979-09       Impact factor: 2.493

10.  Polymorphism of theophylline metabolism in man.

Authors:  C A Miller; L B Slusher; E S Vesell
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

View more
  2 in total

Review 1.  The rheumatoid arthritis HLA-DRB1 shared epitope.

Authors:  Joseph Holoshitz
Journal:  Curr Opin Rheumatol       Date:  2010-05       Impact factor: 5.006

2.  A Comparative Pharmacokinetic Study by UHPLC-MS/MS of Main Active Compounds after Oral Administration of Zushima-Gancao Extract in Normal and Adjuvant-Induced Arthritis Rats.

Authors:  Jinjun Shan; Wenjuan Qian; Linxiu Peng; Lianghui Chen; An Kang; Tong Xie; Liuqing Di
Journal:  Molecules       Date:  2018-01-22       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.